On November 10, 2025 , the Food and Drug Administration (FDA), via the Department of Health & Human Services (HHS), announced that they are initiating the removal of the “black-box” warnings from many hormone replacement therapy (HRT) products used to treat menopausal symptoms. These black-box warnings had been the most stringent warning label the FDA typically places, and they signaled serious risks (e.g., breast cancer, cardiovascular disease, dementia) associated with HRT

Visit Compounding.com for easy-to-understand information on compounded therapies, compliance and quality, and how patients can help protect access to needed medications. This site has many interesting articles including: Compounded Hormones Compounding for Drug Shortages Compounded Ketamine Desiccated Thyroid Extract Is the pharmacy you are planning to use a legitimate, state licensed pharmacy? How misrepresenting compounded drugs hurts patients Advocacy Hub to ensure access

FDA's reclassification of desiccated thyroid extract (DTE) as a biologic is unnecessary, scientifically flawed and harmful to patients.

The menopause podcast with unfiltered conversations about the symptoms you hate, the changes you didn’t see coming, and the hilarious moments midlife can bring. You've got questions and we've got the experts to answer them.